IRIS
CIRIONI, Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.935
EU - Europa 7.366
AS - Asia 6.952
SA - Sud America 1.512
AF - Africa 392
Continente sconosciuto - Info sul continente non disponibili 374
OC - Oceania 19
Totale 33.550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.442
SG - Singapore 2.347
VN - Vietnam 1.380
RU - Federazione Russa 1.276
UA - Ucraina 1.208
BR - Brasile 1.153
CN - Cina 1.094
IT - Italia 1.050
DE - Germania 679
IE - Irlanda 677
SE - Svezia 663
TR - Turchia 588
HK - Hong Kong 573
FR - Francia 468
DK - Danimarca 434
FI - Finlandia 349
GB - Regno Unito 261
KR - Corea 245
CA - Canada 207
CI - Costa d'Avorio 192
IN - India 147
AR - Argentina 126
BD - Bangladesh 117
MX - Messico 104
NL - Olanda 71
EC - Ecuador 63
JP - Giappone 62
ZA - Sudafrica 58
IQ - Iraq 54
ID - Indonesia 50
CO - Colombia 49
PL - Polonia 49
PK - Pakistan 41
MA - Marocco 40
VE - Venezuela 36
UZ - Uzbekistan 35
AT - Austria 32
CR - Costa Rica 31
PH - Filippine 30
ES - Italia 29
PY - Paraguay 28
HN - Honduras 27
IR - Iran 27
BE - Belgio 25
TT - Trinidad e Tobago 23
IL - Israele 22
PE - Perù 20
CL - Cile 19
CW - ???statistics.table.value.countryCode.CW??? 19
EG - Egitto 18
MY - Malesia 18
TN - Tunisia 18
SV - El Salvador 16
PR - Porto Rico 15
LT - Lituania 14
RO - Romania 14
GT - Guatemala 13
JO - Giordania 13
KE - Kenya 13
KZ - Kazakistan 13
JM - Giamaica 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
NI - Nicaragua 11
NP - Nepal 10
OM - Oman 10
UY - Uruguay 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
ET - Etiopia 9
PS - Palestinian Territory 9
TH - Thailandia 9
EU - Europa 8
GP - Guadalupe 8
AZ - Azerbaigian 7
HR - Croazia 7
PA - Panama 7
CH - Svizzera 6
RS - Serbia 6
AL - Albania 5
BO - Bolivia 5
CY - Cipro 5
SC - Seychelles 5
SN - Senegal 5
CG - Congo 4
EE - Estonia 4
GR - Grecia 4
LY - Libia 4
MD - Moldavia 4
NG - Nigeria 4
PT - Portogallo 4
TW - Taiwan 4
AO - Angola 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
Totale 33.150
Salva come PNG Salva come JPEG
Città #
Ashburn 2.850
Singapore 1.415
Jacksonville 1.205
Chandler 1.046
Dallas 859
Fairfield 827
San Jose 734
Dublin 668
Council Bluffs 615
Boardman 614
Hong Kong 550
Wilmington 490
Ho Chi Minh City 450
New York 403
Woodbridge 401
Hanoi 351
Seattle 326
Houston 318
Beijing 292
Ann Arbor 266
Princeton 266
Des Moines 265
Moscow 261
Lawrence 253
Cambridge 250
San Mateo 246
Los Angeles 238
Lauterbourg 220
The Dalles 218
Abidjan 192
Hefei 168
San Diego 121
São Paulo 121
Munich 120
Turin 117
Buffalo 105
Santa Clara 105
Milan 99
Phoenix 85
Centro 83
Da Nang 75
Orem 68
Helsinki 63
Turku 61
Chicago 59
London 58
Montreal 54
Redmond 48
Tokyo 47
Rome 46
Haiphong 43
Atlanta 41
Guangzhou 41
Shanghai 41
Warsaw 39
Chennai 38
Denver 35
Miano 35
Washington 35
Tashkent 34
Ancona 33
Columbus 33
Mexico City 33
Rio de Janeiro 33
Brooklyn 32
Chelsea 30
Izmir 29
Johannesburg 29
Nuremberg 29
Norwalk 28
Manchester 25
Naples 25
Toronto 25
Brasília 24
Brussels 24
Mumbai 23
San Francisco 23
Wuhan 23
Falls Church 22
Hải Dương 22
Amsterdam 21
Belo Horizonte 20
Guayaquil 20
Marche 20
Poplar 20
Porto 20
Biên Hòa 19
Boston 19
Ottawa 19
Stockholm 19
Salt Lake City 18
San José 18
Willemstad 18
Dhaka 17
Vienna 17
Baghdad 16
Bắc Ninh 16
Can Tho 16
Curitiba 16
Frankfurt am Main 16
Totale 20.084
Salva come PNG Salva come JPEG
Nome #
Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound 447
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 341
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 276
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 240
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 221
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 216
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 208
Anticryptosporidial activity of paromomycin. 207
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 205
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 200
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT 199
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 194
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 193
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 193
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 193
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 192
Antimicrobial activity of polycationic peptides 191
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 191
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 189
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 187
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 179
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 173
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 172
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 170
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 169
Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against mbl and esbl co-producing gram-negative clinical isolates: Possible options for the treatment of complicated infections 169
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 167
Epidemiology and microbiology of surgical wound infections. 165
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 163
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 163
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 159
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 159
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 158
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 158
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 158
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 157
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 157
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 156
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 156
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 156
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 155
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 155
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 154
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 152
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 151
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 151
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 151
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 151
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 149
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 148
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 147
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 147
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 147
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 147
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 147
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 146
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 146
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 145
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 145
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 144
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 142
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 142
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 142
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 141
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 140
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 140
Review: A safety profile of dalbavancin for onand off-label utilization 140
ER-mitochondria association negatively affects wound healing by regulating NLRP3 activation 139
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 139
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 139
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 138
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 138
Animal models commonly used to study quorum-sensing inhibitors. 138
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 137
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 136
Antiretroviral therapy management and rationalisation of available resources 136
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 135
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 135
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 135
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 134
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 134
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 134
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 133
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 133
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 132
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 131
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 131
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 131
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 131
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 130
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 130
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 130
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 130
Genomic Analysis of a Linezolid-Resistant Staphylococcus capitis Causing Bacteremia: Report from a University Hospital in Central Italy 129
LL-37 protects rats against lethal gram-negative sepsis. 129
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 129
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 129
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 128
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 128
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 128
Totale 16.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.426 0 0 0 104 33 146 86 117 142 263 130 405
2022/20233.419 338 330 251 242 265 515 5 180 879 18 270 126
2023/20241.945 360 46 132 318 345 408 33 55 17 22 21 188
2024/20254.211 542 331 246 130 156 211 417 165 890 222 411 490
2025/202611.567 663 917 930 1.291 1.086 748 2.083 1.146 1.065 905 261 472
2026/20273.124 666 611 579 1.268 0 0 0 0 0 0 0 0
Totale 33.550